skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Journal Of Clinical Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer

Hoimes, Christopher J ; Flaig, Thomas W ; Milowsky, Matthew I ; Friedlander, Terence W ; Bilen, Mehmet Asim ; Gupta, Shilpa ; Srinivas, Sandy ; Merchan, Jaime R ; McKay, Rana R ; Petrylak, Daniel P ; Sasse, Carolyn ; Moreno, Blanca Homet ; Yu, Yao ; Carret, Anne-Sophie ; Rosenberg, Jonathan E

Journal of clinical oncology, 2023-01, Vol.41 (1), p.22-31 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
2
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
Material Type:
Artigo 		Adicionar ao Meu Espaço

Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater

Reck, Martin ; Rodríguez-Abreu, Delvys ; Robinson, Andrew G ; Hui, Rina ; Csőszi, Tibor ; Fülöp, Andrea ; Gottfried, Maya ; Peled, Nir ; Tafreshi, Ali ; Cuffe, Sinead ; O'Brien, Mary ; Rao, Suman ; Hotta, Katsuyuki ; Vandormael, Kristel ; Riccio, Antonio ; Yang, Jing ; Pietanza, M Catherine ; Brahmer, Julie R

Journal of clinical oncology, 2019-03, Vol.37 (7), p.537-546 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
3
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation

O'Reilly, Eileen M ; Lee, Jonathan W ; Zalupski, Mark ; Capanu, Marinela ; Park, Jennifer ; Golan, Talia ; Tahover, Esther ; Lowery, Maeve A ; Chou, Joanne F ; Sahai, Vaibhav ; Brenner, Robin ; Kindler, Hedy L ; Yu, Kenneth H ; Zervoudakis, Alice ; Vemuri, Shreya ; Stadler, Zsofia K ; Do, Richard K G ; Dhani, Neesha ; Chen, Alice P ; Kelsen, David P

Journal of clinical oncology, 2020-05, Vol.38 (13), p.1378-1388 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)

Ferris, Robert L ; Flamand, Yael ; Weinstein, Gregory S ; Li, Shuli ; Quon, Harry ; Mehra, Ranee ; Garcia, Joaquin J ; Chung, Christine H ; Gillison, Maura L ; Duvvuri, Umamaheswar ; O'Malley, Jr, Bert W ; Ozer, Enver ; Thomas, Giovana R ; Koch, Wayne M ; Gross, Neil D ; Bell, R Bryan ; Saba, Nabil F ; Lango, Miriam ; Méndez, Eduardo ; Burtness, Barbara

Journal of clinical oncology, 2022-01, Vol.40 (2), p.138-149 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
5
Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209)
Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209)

Miller, David S ; Filiaci, Virginia L ; Mannel, Robert S ; Cohn, David E ; Matsumoto, Takashi ; Tewari, Krishnansu S ; DiSilvestro, Paul ; Pearl, Michael L ; Argenta, Peter A ; Powell, Matthew A ; Zweizig, Susan L ; Warshal, David P ; Hanjani, Parviz ; Carney, Michael E ; Huang, Helen ; Cella, David ; Zaino, Richard ; Fleming, Gini F

Journal of clinical oncology, 2020-11, Vol.38 (33), p.3841-3850 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
6
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial

Zhong, Wen-Zhao ; Wang, Qun ; Mao, Wei-Min ; Xu, Song-Tao ; Wu, Lin ; Wei, Yu-Cheng ; Liu, Yong-Yu ; Chen, Chun ; Cheng, Ying ; Yin, Rong ; Yang, Fan ; Ren, Sheng-Xiang ; Li, Xiao-Fei ; Li, Jian ; Huang, Cheng ; Liu, Zhi-Dong ; Xu, Shun ; Chen, Ke-Neng ; Xu, Shi-Dong ; Liu, Lun-Xu ; Yu, Ping ; Wang, Bu-Hai ; Ma, Hai-Tao ; Yang, Jin-Ji ; Yan, Hong-Hong ; Yang, Xue-Ning ; Liu, Si-Yang ; Zhou, Qing ; Wu, Yi-Long

Journal of clinical oncology, 2021-03, Vol.39 (7), p.713-722 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
7
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

SEQUIST, Lecia V ; YANG, James Chih-Hsin ; SU, Wu-Chou ; BENNOUNA, Jaafar ; KATO, Terufumi ; GORBUNOVA, Vera ; KI HYEONG LEE ; SHAH, Riyaz ; MASSEY, Dan ; ZAZULINA, Victoria ; SHAHIDI, Mehdi ; SCHULER, Martin ; YAMAMOTO, Nobuyuki ; O'BYRNE, Kenneth ; HIRSH, Vera ; MOK, Tony ; GEATER, Sarayut Lucien ; ORLOV, Sergey ; TSAI, Chun-Ming ; BOYER, Michael

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3327-3334 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
8
Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR -Mutant Non-Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study
Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR -Mutant Non-Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR -Mutant Non-Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study

Zhong, Wen-Zhao ; Chen, Ke-Neng ; Chen, Chun ; Gu, Chun-Dong ; Wang, Jun ; Yang, Xue-Ning ; Mao, Wei-Min ; Wang, Qun ; Qiao, Gui-Bin ; Cheng, Ying ; Xu, Lin ; Wang, Chang-Li ; Chen, Ming-Wei ; Kang, Xiaozheng ; Yan, Wanpu ; Yan, Hong-Hong ; Liao, Ri-Qiang ; Yang, Jin-Ji ; Zhang, Xu-Chao ; Zhou, Qing ; Wu, Yi-Long

Journal of clinical oncology, 2019-09, Vol.37 (25), p.2235-2245 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
9
Development and Validation of a Risk Prediction Model for Acute Kidney Injury After the First Course of Cisplatin
Development and Validation of a Risk Prediction Model for Acute Kidney Injury After the First Course of Cisplatin
Material Type:
Artigo 		Adicionar ao Meu Espaço

Development and Validation of a Risk Prediction Model for Acute Kidney Injury After the First Course of Cisplatin

Motwani, Shveta S ; McMahon, Gearoid M ; Humphreys, Benjamin D ; Partridge, Ann H ; Waikar, Sushrut S ; Curhan, Gary C

Journal of clinical oncology, 2018-03, Vol.36 (7), p.682-688 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
10
Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial
Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial

Ishigami, Hironori ; Fujiwara, Yoshiyuki ; Fukushima, Ryoji ; Nashimoto, Atsushi ; Yabusaki, Hiroshi ; Imano, Motohiro ; Imamoto, Haruhiko ; Kodera, Yasuhiro ; Uenosono, Yoshikazu ; Amagai, Kenji ; Kadowaki, Shigenori ; Miwa, Hiroto ; Yamaguchi, Hironori ; Yamaguchi, Takuhiro ; Miyaji, Tempei ; Kitayama, Joji

Journal of clinical oncology, 2018-07, Vol.36 (19), p.1922-1929 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.